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The objective of this study was to test whether the temporal patterns of VT recurrences in
patients with implantable cardioverter-defibrillator (ICD) follow a random or a clustered
pattern by mathematical modeling. METHODS: Data analysis was conducted using the
Medtronic Gem DR database of 521 ICD patients. Patients with > 3 spontaneous VT
detections during follow up were studied. The times between consecutive treated VT
detections (inter-event interval) for each patient were compared to an exponential model
of random recurrences and a Weibull model to test for clustering of recurrences.
RESULTS: 71 patients had > 3 VT episodes during a mean follow-up of 131 days. A total
of 2347 VT episodes were recorded (33+65 episodes/patient, median 10 episodes /
patient). Patient age 66+13 years, 78% male, 83% coronary artery disease, ejection frac-
tion 31+11%, 63% taking antiarrhythmic drugs. The inter-event interval was less than 1
hour for 78% of all intervals and was less than 91 hours for 94% of inter-event intervals.
By the Kolmogorov Smirnov goodness-of-fit test, 38 out of 71 patients (53.5%) showed
that the distribution of inter-detection intervals differed from an exponential model (p <
0.01 for each patient, p = 0.65 for proportion of patients similar to chance), while only 11
out of 71 patients (15.5%) showed that the distribution of inter-detection intervals differed
from a Weibull model (p < 0.01 for each patient, p < 0.001 for proportion of patients simi-
lar to chance). CONCLUSION: The recurrence pattern of treated VT events in ICD
patients are clustered and are more frequently described by a Weibull distribution than a
random distribution. The time between consecutive treated VT detections is usually < 1
hour and infrequently > 91 hours. Knowledge of this pattern may help to design studies of
new antiarrhythmic therapies.
1053-213 The Predictive Value of Electrophysiologic Testing: 
Subgroup Analysis in the Dual Chamber and VVI 
Implantable Defibrillator (DAVID) Trial
Nicholas G. Tullo, Anil K. Bhandari, Anne H. Dougherty, G. Stephen Greer, Maribel 
Hernandez, Gregory Michaud, Alfred Hallstrom, Anna O. Leonen, Ellen G. Renfroe, and 
the DAVID Investigators, University of Washington, Seattle, WA
Background: The DAVID Trial evaluated whether dual-chamber pacing was superior to
single chamber pacing in patients (pts) with an ejection fraction of less than 40% who
were receiving an implantable cardioverter-defibrillator (ICD). The result of a baseline
electrophysiologic study (EPS) in trial pts was reviewed to determine if inducibility of ven-
tricular arrhythmias predicted outcome.
Methods: A total of 506 pts were enrolled in the DAVID Trial. Baseline EPS was recom-
mended but not required except for pts enrolled because of unexplained syncope. The
induction protocol involved up to 3 premature extrastimuli at 2 drive cycle lengths from up
to 2 sites in the right ventricle. Induced arrhythmias were classified based on morphology,
rate, and duration.
Results: Of the pts enrolled in the trial, 313 had a baseline EPS. A comparison of demo-
graphic and clinical parameters between the pts who underwent EPS and those who did
not revealed few substantial differences. At the time of EPS 81% of pts were on drug
therapy, including 60% who were on beta blockers, 29% on digoxin, 10% on calcium
blockers, and 15% on Class I or III antiarrhythmic drugs. The worst arrhythmia induced
was sustained VF in 40 pts, sustained monomorphic VT > 250 bpm in 72 pts, sustained
monomorphic VT 201-250 bpm in 106 pts, sustained monomorphic VT 150-200 bpm in
34 pts, sustained monomorphic VT < 150 bpm in 10 pts, sustained polymorphic VT in 31
pts, non-sustained polymorphic VT in 5 pts, non-sustained monomorphic VT in 3 pts,
less than 15 beats of VT in 3 pts, and no VT in 9 pts. Kaplan-Meier survival analysis
showed no significant difference between inducibility or non-inducibility of the rhythm
classifications with respect to the time to first recurrent arrhythmia, time to first inappro-
priate therapy or time to first re-hospitalization, but time to the primary endpoint (death or
hospitalization for congestive heart failure) was shorter for non-inducible patients and
longest for patients with VF or polymorphic VT induced (p=.01).
Conclusion: In the DAVID pts who underwent EPS, inducibility of VT/VF appears to pre-
dict outcome with regard to survival / hospitalization for heart failure, but not for future
ICD therapies or hospitalization in general.
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1071-207 Expedited Geometric Rendering of Left Atrium and 
Pulmonary Veins Using Multipoint Electroanatomical 
Mapping
Martin D. Lowe, Laurie A. Peterson, Douglas L. Packer, Mayo Clinic, Rochester, MN
Background: Conventional electroanatomic mapping of the left atrium (LA) and pulmo-
nary veins (PVs) can be both time-consuming and laborious. An accelerated mapping
capability with simultaneous acquisition of multiple points would be clearly advantageous
in facilitating AF ablation.
Methods: We compared integrated multipoint electroanatomical mapping and geometric
rendering of LA and PVs with tip mapping alone in 17 patients undergoing AF ablation.
Eight patients (3 paroxysmal, 5 persistent AF) underwent mapping of LA and each PV
with a multipolar catheter (QwikStar, Biosense), that allowed simultaneous acquisition of
tip, shaft and trace point data from its distal 6 cm. Nine patients who underwent tip map-
ping alone (NaviStar, Biosense), were used as controls. Study patients had an ejection
fraction of 48 ± 16 %, an LA size of 44 ± 3 mm, and had failed 3.1 ± 1.3 antiarrhythmic
drugs, all values similar to controls.
Results: The LA was mapped and geometrically rendered much faster in study patients
than controls (11 ± 5.8 vs. 23 ± 12 minutes). In addition, multipoint mapping with 53 ± 29
tip, 83 ± 31 shaft and 84 ± 117 trace points required less catheter manipulation than con-
trol patients where 111 ± 57 tip points were needed for adequate rendering of LA anat-
omy. In study patients PV mapping required 3.5 ± 2.1 minutes with the LSPV rendered
using 22 ± 7 tip points and 76 ± 41 shaft points, LIPV 25 ± 8 and 69 ± 43, RSPV 24 ± 6
and 49 ± 36, and RIPV 20 ± 6 and 44 ± 30, tip and shaft points. PV trace points were not
required to obtain optimal venous geometry. In controls PVs were mapped in 3.4 ± 2.8
minutes per vein with 62 ± 28 tip points. Although PV mapping times were similar in both
groups, simultaneous multipoint mapping required less catheter movement and tip point
acquisition. The greater number of points in LA and PVs obtained in the study group
allowed for a more qualitatively precise geometric rendering of LA and PVs with clearer
demarcation of PV ostia.
Conclusion: This study demonstrates substantial reduction in LA mapping time by inte-
grated tip and shaft point mapping. The creation of a more anatomically correct rendering
of the LA-PV junction may facilitate ablative intervention, with improved targeting of
energy delivery.
1071-208 Circumferential and Combined Technique in 
Cryoisolation of Pulmonary Veins: The "Arctic Circler" 
Experience
Juergen Vogt, Johannes Heintze, Helga Buschler, Peter Schwartze, Dieter Horstkotte, 
Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Discrete sequential single pulsed isolation of the pulmonary veins (PV) with radiofre-
quency (RF) or cryotechnique with a 6-mm tip catheter is associated with many ostial
impulses and in RF with the risk of PV stenoses.
Guided by a 20-pole Lasso catheter before and after ablation, proximal PV isolation was
performed using the self-expanding arctic circler (AC) with a maximum of 30 mm in diam-
eter over 4 minutes of cryoimpulses (CI) at a temperature of -75 °C to -90°C (with N2O
cryo technique). Electrical gaps were closed under Lasso guidance using a 6-mm tip cry-
ocatheter (freezor xtra, Cryocath, Canada).
Of 35 patients (P) (9 women, age 59±7 years refractory to antiarrhythmic therapy, 33 with
paroxysmal, 2 with persistent atrial fibrillation (AF), mean duration 87±70 months) 22
were treated in a first attempt, 13 after ablation 3 months ago because of AF recurrence.
Of 125 PV 15 were re-isolated with the 6-mm tip cryocatheter because of single or few
inputs only. One hundred and ten PV were isolated with the arctic circler alone in 54%
(59 PV), with additional gap closing by the freezor in 46% (51 PV). Gap closing was more
(70%) required in the left upper PV (Table). There were no acute PV stenoses nor
stenoses after 3 months.
Conclusion: AC isolation of PV is successful in 54% with few CI only and in 100% with
additional gap closing with a conventional cryoablation.
1071-219 Remodeling of the Left Atrium and Pulmonary Veins 
Following Catheter Ablation of Atrial Fibrillation
Darshan Dalal, Vinod Jayam, Chandrasekhar R. Vasamreddy, Lars Lickfett, Dave 
Bradley, Zayd Eldadah, Timm Dickfeld, Henry Halperin, Ronald Berger, Hugh Calkins, 
Johns Hopkins University School of Medicine, Baltimore, MD
Background: Catheter ablation of atrial fibrillation (AF) has been shown to be a curative
approach for treatment of AF. The purpose of this study was to determine to what extent
catheter ablation of AF results in reverse remodeling of left atrial and pulmonary vein
(PV) size.
Methods: The patient population was comprised of 54 patients (40 male, 54+11 years)
who underwent catheter ablation for AF. Each patient had a gadolinium enhanced mag-
netric resonance scan prior to and 6-8 weeks following ablation. The diameters of the
PVs and the oblique axial, coronal, and sagital dimensions of the left atrium were deter-
mined. The left atrial volume was then calculated.
Results: The mean ± SD decrease in LA Volume was 12 ± 22% (p<0.001). The mean ±
SD decrease (mm) in the PV diameter was from 18.1 ± 2.9 to 16.6 ± 3.1 in Left Superior
(LS) PV, 17.5 ± 3.2 to 15.4 ± 4.0 in Left Inferior (LI) PV, 19.5 ± 3.5 to 17.1 ± 4.1 for Right
Superior (RS) PV and 19.0 ± 3.8 to 17.8 ± 4.3 in Right Inferior (RI) PV (p<0.01 for each).
LA volume change had a linear correlation with the reduction in diameter of each of the
four PVs. Percent change in diameter of each PV ostium showed correlation with percent
change in diameter of the other ostia except for LSPV and RIPV (figure). Overall, percent
change in diameter of ostia of all PVs correlated with the percent change in LA volume
(p<0.01).
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Left upper (n=31) 5.4±1.6 11 (30%) 20 6.4±5 100 18±4
Left lower (n=23) 3.6±1.1 15 (65%) 8 5.0±2 100 17±2
Right upper (n=29) 4.4±1.4 17 (58%) 12 5.0±3 100 17±3
Right lower (n=27) 3.3±0.9 16 (59%) 11 4.0±2 100 17±3
